Pre-made Suvratoxumab benchmark antibody ( Whole mAb, anti-Toxin A therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Suvratoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Suvratoxumab (INN; development code MEDI4893) is a human monoclonal antibody designed for the prevention of nosocomial pneumonia caused by Staphylococcus aureus.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-539-1mg	1mg	3090
GMP-Bios-ab-539-10mg	10mg	Inquiry
GMP-Bios-ab-539-100mg	100mg	Inquiry
GMP-Bios-ab-539-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Suvratoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody
INN Name	Suvratoxumab
Target	Toxin A
Format	Whole mAb
Derivation	Human
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-II
Est. Status	Active
100% SI Structure	4u6v:HL:KM
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2016
Year Recommended	2017
Companies	Biosynexus;GlaxoSmithKline;Regeneron Pharmaceuticals;MedImmune
Conditions Approved	na
Conditions Active	Nosocomial pneumonia
Conditions Discontinued	na
Development Tech	na